Shandong Sanyuan Biotechnology Stock Current Valuation
| 301206 Stock | 29.07 0.28 0.95% |
Valuation analysis of Shandong Sanyuan Bio helps investors to measure Shandong Sanyuan's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Shandong Sanyuan's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 2 M, whereas Cash is forecasted to decline to about 103.4 M. Fundamental drivers impacting Shandong Sanyuan's valuation include:
Price Book 1.2541 | Enterprise Value 5.5 B | Enterprise Value Ebitda 23.1299 | Price Sales 8.9535 | Trailing PE 61.1458 |
Fairly Valued
Today
Please note that Shandong Sanyuan's price fluctuation is very steady at this time. Calculation of the real value of Shandong Sanyuan Bio is based on 3 months time horizon. Increasing Shandong Sanyuan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shandong Sanyuan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shandong Stock. However, Shandong Sanyuan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.07 | Real 28.28 | Hype 29.45 | Naive 29.19 |
The real value of Shandong Stock, also known as its intrinsic value, is the underlying worth of Shandong Sanyuan Bio Company, which is reflected in its stock price. It is based on Shandong Sanyuan's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shandong Sanyuan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shandong Sanyuan Biotechnology helps investors to forecast how Shandong stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shandong Sanyuan more accurately as focusing exclusively on Shandong Sanyuan's fundamentals will not take into account other important factors: Shandong Sanyuan Biotechnology Company Current Valuation Analysis
Shandong Sanyuan's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Shandong Sanyuan Current Valuation | 5.46 B |
Most of Shandong Sanyuan's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shandong Sanyuan Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Shandong Sanyuan Biotechnology has a Current Valuation of 5.46 B. This is 71.86% lower than that of the Food Products sector and 77.52% lower than that of the Consumer Staples industry. The current valuation for all China stocks is 67.15% higher than that of the company.
Shandong Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shandong Sanyuan's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shandong Sanyuan could also be used in its relative valuation, which is a method of valuing Shandong Sanyuan by comparing valuation metrics of similar companies.Shandong Sanyuan is currently under evaluation in current valuation category among its peers.
Shandong Fundamentals
| Return On Equity | 0.0217 | ||||
| Return On Asset | -0.0017 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 5.46 B | ||||
| Shares Outstanding | 202.33 M | ||||
| Shares Owned By Insiders | 60.35 % | ||||
| Shares Owned By Institutions | 16.19 % | ||||
| Price To Book | 1.25 X | ||||
| Price To Sales | 8.95 X | ||||
| Revenue | 499.5 M | ||||
| Gross Profit | 94.86 M | ||||
| EBITDA | 62.1 M | ||||
| Net Income | 58.87 M | ||||
| Total Debt | 272.4 M | ||||
| Book Value Per Share | 22.43 X | ||||
| Cash Flow From Operations | 57.31 M | ||||
| Earnings Per Share | 0.48 X | ||||
| Target Price | 32.0 | ||||
| Number Of Employees | 427 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 5.94 B | ||||
| Total Asset | 4.81 B | ||||
| Retained Earnings | 745.06 M | ||||
| Working Capital | 97.62 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 4.81 B | ||||
| Last Dividend Paid | 0.4 |
About Shandong Sanyuan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shandong Sanyuan Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shandong Sanyuan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shandong Sanyuan Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shandong Stock
Shandong Sanyuan financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Sanyuan security.